|
|
Volumn 8, Issue 7, 2009, Pages 525-526
|
|
Teaming up to tackle RNAi delivery challenge
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AEG 35156;
AGN 211745;
ALN RSV 01;
ANTISENSE OLIGONUCLEOTIDE;
BEVASIRANIB;
LIPID;
LIPOSOME;
MICROSPHERE;
NUCLEIC ACID;
PF 04523655;
POLYMER;
QPI 1002;
SINGLE STRANDED RNA;
SMALL INTERFERING RNA;
TOLL LIKE RECEPTOR;
UNCLASSIFIED DRUG;
ARTICLE;
CLINICAL TRIAL;
DRUG COATING;
DRUG CONFORMATION;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG HALF LIFE;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG SAFETY;
DRUG STABILITY;
DRUG TARGETING;
GENE EXPRESSION REGULATION;
GENE SILENCING;
HUMAN;
LIPOSOMAL DELIVERY;
NONHUMAN;
PRIORITY JOURNAL;
PROCESS TECHNOLOGY;
RNA INTERFERENCE;
STABLE NUCLEIC ACID LIPID PARTICLE DELIVERY SYSTEM;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
DRUG DELIVERY SYSTEMS;
HUMANS;
LIPIDS;
RNA INTERFERENCE;
|
|
EID: 67650071125
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2940 Document Type: Article |
|
Times cited : (10)
|
|
References (0)
|